Mesoblast (MESO) Goodwill & Intangibles (2015 - 2025)
Mesoblast (MESO) posted quarterly Goodwill & Intangibles of $568.8 million for Q4 2025, down 1.06% year-on-year from $574.9 million in Q4 2024, and down 0.53% on a QoQ basis from $571.8 million in Q2 2025.
Mesoblast (MESO) Goodwill & Intangibles (2015 - 2025) Analysis & Trends
Mesoblast (MESO) has reported Goodwill & Intangibles for 11 consecutive years, with $568.8 million the latest figure, recorded in Q4 2025.
- Quarterly Goodwill & Intangibles fell 1.06% year-over-year to $568.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $568.8 million (down 1.06% YoY) and the FY2025 annual result came in at $571.8 million, down 0.68% from the prior year.
- Goodwill & Intangibles declined to $568.8 million in Q4 2025 per MESO's latest filing, from $571.8 million in the prior quarter.
- Over the last five years, Goodwill & Intangibles for MESO reached as high as $698.9 million in Q2 2021 and fell as low as $568.8 million in Q4 2025.
- A 5-year average of $593.1 million and a median of $578.3 million in 2022 frame the typical range for Goodwill & Intangibles.
- Annual changes were most pronounced in 2021 — Goodwill & Intangibles rose 20.18% — and 2023, when it decreased 16.9%.
- Year by year, Goodwill & Intangibles stood at $579.8 million in 2021, then slipped by 0.33% to $577.9 million in 2022, then fell by 0.23% to $576.6 million in 2023, then declined by 0.29% to $574.9 million in 2024, then slipped by 1.06% to $568.8 million in 2025.
- According to Business Quant data, Goodwill & Intangibles over the past three periods registered $568.8 million, $571.8 million, and $574.9 million for Q4 2025, Q2 2025, and Q4 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Mesoblast | 2.08 Bn | 1.95 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 568.80 Mn |
| Jun 30, 2025 | 571.83 Mn |
| Dec 31, 2024 | 574.88 Mn |
| Jun 30, 2024 | 575.74 Mn |
| Dec 31, 2023 | 576.56 Mn |
| Jun 30, 2023 | 579.28 Mn |
| Mar 31, 2023 | 577.53 Mn |
| Dec 31, 2022 | 577.90 Mn |
| Sep 30, 2022 | 578.28 Mn |
| Jun 30, 2022 | 697.05 Mn |
| Mar 31, 2022 | 578.95 Mn |
| Dec 31, 2021 | 579.84 Mn |
| Sep 30, 2021 | 580.18 Mn |
| Jun 30, 2021 | 698.95 Mn |
| Mar 31, 2021 | 580.94 Mn |
| Dec 31, 2020 | 581.33 Mn |
| Sep 30, 2020 | 581.22 Mn |
| Jun 30, 2020 | 581.60 Mn |
| Mar 31, 2020 | 581.94 Mn |
| Dec 31, 2019 | 582.34 Mn |